Abstract
The possible role of immunomodulatory peptide somatostatin (SRIF) in measles virus (MV)-induced immunopathology was addressed by analysis of SRIF receptors and their coupling to adenylyl cyclase in mitogen-stimulated Jurkat T cells and human peripheral blood mononuclear cells (PBMC). SRIF-specific receptors were assayed in semipurified membrane preparations by using SRIF14 containing iodinated tyrosine at the first position in the amino acid chain ([125I]Tyr1) as a radioligand. A determination of receptor number by saturation of radioligand binding at equilibrium showed that in Jurkat cells, MV infection led to a dramatic decrease in the total receptor number. The virus-associated disappearance of one (Ki2 = 12 +/- 4 nM [mean +/- standard error of the mean [SEM]]; n = 4) of two somatostatin binding sites identified in control Jurkat cells (Ki1 = 78 +/- 3 pM and Ki2 = 12 +/- 4 nM [mean +/- SEM]; n = 4) was also observed. Almost identical results were obtained for phytohemagglutinin-activated human PBMC. In the absence of MV infection, two somatostatin binding sites were present (Ki1 = 111 +/- 31 pM and Ki2 = 17 +/- 2 nM [mean +/- SEM]; n = 2), whereas in MV-infected cells, only the high-affinity (Ki1 = 48 +/- 15 pM [mean +/- SEM]; n = 2) binding site remained. In addition, MV infection reinforced the inhibitory effects of SRIF on adenylyl cyclase activity, since maximal inhibition at 1 microM peptide was 11% +/- 4% in control cells versus 25% +/- 3% (P < 0.05) in infected Jurkat cells. Moreover, MV infection severely impaired the capacity of adenylyl cyclase to be activated directly (by forskolin) or indirectly (via Gs protein-coupled vasoactive intestinal peptide receptor). An assessment of [methyl-3H]thymidine incorporation showed that SRIF increased proliferative responses to mitogens only in control cells, not in MV-infected cells. Altogether, our data emphasize that MV-associated alteration of SRIF transduction appears to be related to the loss of SRIF-dependent increase of mitogen-induced proliferation.
Full Text
The Full Text of this article is available as a PDF (189.5 KB).
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aguila M. C., Dees W. L., Haensly W. E., McCann S. M. Evidence that somatostatin is localized and synthesized in lymphoid organs. Proc Natl Acad Sci U S A. 1991 Dec 15;88(24):11485–11489. doi: 10.1073/pnas.88.24.11485. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Audinot V., Rasolonjanahary R., Bertrand P., Priam M., Kordon C., Enjalbert A. Involvement of protein kinase-C in the effect of angiotensin-II on adenosine 3',5'-monophosphate production in lactotroph cells. Endocrinology. 1991 Oct;129(4):2231–2239. doi: 10.1210/endo-129-4-2231. [DOI] [PubMed] [Google Scholar]
- Battaglia G., Norman A. B., Hess E. J., Creese I. D2 dopamine receptor-mediated inhibition of forskolin-stimulated adenylate cyclase activity in rat striatum. Neurosci Lett. 1985 Aug 30;59(2):177–182. doi: 10.1016/0304-3940(85)90196-x. [DOI] [PubMed] [Google Scholar]
- Beckner S. K., Farrar W. L. Potentiation of lymphokine-activated killer cell differentiation and lymphocyte proliferation by stimulation of protein kinase C or inhibition of adenylate cyclase. J Immunol. 1988 Jan 1;140(1):208–214. [PubMed] [Google Scholar]
- Bell G. I., Reisine T. Molecular biology of somatostatin receptors. Trends Neurosci. 1993 Jan;16(1):34–38. doi: 10.1016/0166-2236(93)90050-v. [DOI] [PubMed] [Google Scholar]
- Bhathena S. J., Louie J., Schechter G. P., Redman R. S., Wahl L., Recant L. Identification of human mononuclear leukocytes bearing receptors for somatostatin and glucagon. Diabetes. 1981 Feb;30(2):127–131. doi: 10.2337/diab.30.2.127. [DOI] [PubMed] [Google Scholar]
- Bloom B. R. Vaccines for the Third World. Nature. 1989 Nov 9;342(6246):115–120. doi: 10.1038/342115a0. [DOI] [PubMed] [Google Scholar]
- Blum A. M., Metwali A., Mathew R. C., Cook G., Elliott D., Weinstock J. V. Granuloma T lymphocytes in murine schistosomiasis mansoni have somatostatin receptors and respond to somatostatin with decreased IFN-gamma secretion. J Immunol. 1992 Dec 1;149(11):3621–3626. [PubMed] [Google Scholar]
- Enjalbert A., Sladeczek F., Guillon G., Bertrand P., Shu C., Epelbaum J., Garcia-Sainz A., Jard S., Lombard C., Kordon C. Angiotensin II and dopamine modulate both cAMP and inositol phosphate productions in anterior pituitary cells. Involvement in prolactin secretion. J Biol Chem. 1986 Mar 25;261(9):4071–4075. [PubMed] [Google Scholar]
- Epelbaum J., Enjalbert A., Krantic S., Musset F., Bertrand P., Rasolonjanahary R., Shu C., Kordon C. Somatostatin receptors on pituitary somatotrophs, thyrotrophs, and lactotrophs: pharmacological evidence for loose coupling to adenylate cyclase. Endocrinology. 1987 Dec;121(6):2177–2185. doi: 10.1210/endo-121-6-2177. [DOI] [PubMed] [Google Scholar]
- Florio T., Scorizello A., Fattore M., D'Alto V., Salzano S., Rossi G., Berlingieri M. T., Fusco A., Schettini G. Somatostatin inhibits PC Cl3 thyroid cell proliferation through the modulation of phosphotyrosine activity. Impairment of the somatostatinergic effects by stable expression of E1A viral oncogene. J Biol Chem. 1996 Mar 15;271(11):6129–6136. doi: 10.1074/jbc.271.11.6129. [DOI] [PubMed] [Google Scholar]
- Giraudon P., Wild T. F. Correlation between epitopes on hemagglutinin of measles virus and biological activities: passive protection by monoclonal antibodies is related to their hemagglutination inhibiting activity. Virology. 1985 Jul 15;144(1):46–58. doi: 10.1016/0042-6822(85)90303-4. [DOI] [PubMed] [Google Scholar]
- Goetzl E. J., Payan D. G. Inhibition by somatostatin of the release of mediators from human basophils and rat leukemic basophils. J Immunol. 1984 Dec;133(6):3255–3259. [PubMed] [Google Scholar]
- Halbach M., Koschel K. Impairment of hormone dependent signal transfer by chronic SSPE virus infection. J Gen Virol. 1979 Mar;42(3):615–619. doi: 10.1099/0022-1317-42-3-615. [DOI] [PubMed] [Google Scholar]
- Haour F., Marquette C., Tsiang H., Ban E., Crumeyrolle-Arias M., Rostene W., Fillion G. Interleukin-1 receptors in brain and pituitary. Characterization and modulation during infection and stress. Ann N Y Acad Sci. 1994 Nov 25;741:324–337. doi: 10.1111/j.1749-6632.1994.tb39675.x. [DOI] [PubMed] [Google Scholar]
- Hinterberger W., Cerny C., Kinast H., Pointner H., Tragl K. H. Somatostatin reduces the release of colony-stimulating activity (CSA) from PHA-activated mouse spleen lymphocytes. Experientia. 1978 Jul 15;34(7):860–862. doi: 10.1007/BF01939667. [DOI] [PubMed] [Google Scholar]
- Hiruma K., Koike T., Nakamura H., Sumida T., Maeda T., Tomioka H., Yoshida S., Fujita T. Somatostatin receptors on human lymphocytes and leukaemia cells. Immunology. 1990 Dec;71(4):480–485. [PMC free article] [PubMed] [Google Scholar]
- Hofmann B., Nishanian P., Nguyen T., Insixiengmay P., Fahey J. L. Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes. Proc Natl Acad Sci U S A. 1993 Jul 15;90(14):6676–6680. doi: 10.1073/pnas.90.14.6676. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hofmann B., Nishanian P., Nguyen T., Liu M., Fahey J. L. Restoration of T-cell function in HIV infection by reduction of intracellular cAMP levels with adenosine analogues. AIDS. 1993 May;7(5):659–664. doi: 10.1097/00002030-199305000-00008. [DOI] [PubMed] [Google Scholar]
- Iyengar R. Molecular and functional diversity of mammalian Gs-stimulated adenylyl cyclases. FASEB J. 1993 Jun;7(9):768–775. doi: 10.1096/fasebj.7.9.8330684. [DOI] [PubMed] [Google Scholar]
- Jakobs K. H., Aktories K., Schultz G. A nucleotide regulatory site for somatostatin inhibition of adenylate cyclase in S49 lymphoma cells. Nature. 1983 May 12;303(5913):177–178. doi: 10.1038/303177a0. [DOI] [PubMed] [Google Scholar]
- Julius M. H., Simpson E., Herzenberg L. A. A rapid method for the isolation of functional thymus-derived murine lymphocytes. Eur J Immunol. 1973 Oct;3(10):645–649. doi: 10.1002/eji.1830031011. [DOI] [PubMed] [Google Scholar]
- Kimata H., Yoshida A., Fujimoto M., Mikawa H. Effect of vasoactive intestinal peptide, somatostatin, and substance P on spontaneous IgE and IgG4 production in atopic patients. J Immunol. 1993 May 15;150(10):4630–4640. [PubMed] [Google Scholar]
- Koschel K., Muenzel P. Persistent paramyxovirus infections and behaviour of beta-adrenergic receptors in C-6 rat glioma cells. J Gen Virol. 1980 Apr;47(2):513–517. doi: 10.1099/0022-1317-47-2-513. [DOI] [PubMed] [Google Scholar]
- Krantic S., Robitaille Y., Quirion R. Deficits in the somatostatin SS1 receptor sub-type in frontal and temporal cortices in Alzheimer's disease. Brain Res. 1992 Feb 28;573(2):299–304. doi: 10.1016/0006-8993(92)90776-6. [DOI] [PubMed] [Google Scholar]
- LOWRY O. H., ROSEBROUGH N. J., FARR A. L., RANDALL R. J. Protein measurement with the Folin phenol reagent. J Biol Chem. 1951 Nov;193(1):265–275. [PubMed] [Google Scholar]
- Lefkowitz R. J., Stadel J. M., Caron M. G. Adenylate cyclase-coupled beta-adrenergic receptors: structure and mechanisms of activation and desensitization. Annu Rev Biochem. 1983;52:159–186. doi: 10.1146/annurev.bi.52.070183.001111. [DOI] [PubMed] [Google Scholar]
- McChesney M. B., Altman A., Oldstone M. B. Suppression of T lymphocyte function by measles virus is due to cell cycle arrest in G1. J Immunol. 1988 Feb 15;140(4):1269–1273. [PubMed] [Google Scholar]
- McChesney M. B., Kehrl J. H., Valsamakis A., Fauci A. S., Oldstone M. B. Measles virus infection of B lymphocytes permits cellular activation but blocks progression through the cell cycle. J Virol. 1987 Nov;61(11):3441–3447. doi: 10.1128/jvi.61.11.3441-3447.1987. [DOI] [PMC free article] [PubMed] [Google Scholar]
- McPherson G. A. A practical computer-based approach to the analysis of radioligand binding experiments. Comput Programs Biomed. 1983 Aug-Oct;17(1-2):107–113. doi: 10.1016/0010-468x(83)90031-4. [DOI] [PubMed] [Google Scholar]
- Mercure L., Phaneuf D., Wainberg M. A. Differential effect of the immunomodulatory hormone somatostatin on replication of human immunodeficiency virus type 1 in CD4+ and CD8+ T lymphocytes. Clin Diagn Lab Immunol. 1995 Mar;2(2):192–198. doi: 10.1128/cdli.2.2.192-198.1995. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Naniche D., Wild T. F., Rabourdin-Combe C., Gerlier D. A monoclonal antibody recognizes a human cell surface glycoprotein involved in measles virus binding. J Gen Virol. 1992 Oct;73(Pt 10):2617–2624. doi: 10.1099/0022-1317-73-10-2617. [DOI] [PubMed] [Google Scholar]
- Naniche D., Wild T. F., Rabourdin-Combe C., Gerlier D. Measles virus haemagglutinin induces down-regulation of gp57/67, a molecule involved in virus binding. J Gen Virol. 1993 Jun;74(Pt 6):1073–1079. doi: 10.1099/0022-1317-74-6-1073. [DOI] [PubMed] [Google Scholar]
- Niedermühlbichler M., Wiedermann C. J. Suppression of superoxide release from human monocytes by somatostatin-related peptides. Regul Pept. 1992 Sep 3;41(1):39–47. doi: 10.1016/0167-0115(92)90512-s. [DOI] [PubMed] [Google Scholar]
- Nio D. A., Moylan R. N., Roche J. K. Modulation of T lymphocyte function by neuropeptides. Evidence for their role as local immunoregulatory elements. J Immunol. 1993 Jun 15;150(12):5281–5288. [PubMed] [Google Scholar]
- Nokta M., Pollard R. Human immunodeficiency virus infection: association with altered intracellular levels of cAMP and cGMP in MT-4 cells. Virology. 1991 Mar;181(1):211–217. doi: 10.1016/0042-6822(91)90486-u. [DOI] [PubMed] [Google Scholar]
- Pawlikowski M., Stepien H., Kunert-Radek J., Schally A. V. Effect of somatostatin on the proliferation of mouse spleen lymphocytes in vitro. Biochem Biophys Res Commun. 1985 May 31;129(1):52–55. doi: 10.1016/0006-291x(85)91401-9. [DOI] [PubMed] [Google Scholar]
- Pawlikowski M., Stepień H., Kunert-Radek J., Zelazowski P., Schally A. V. Immunomodulatory action of somatostatin. Ann N Y Acad Sci. 1987;496:233–239. doi: 10.1111/j.1749-6632.1987.tb35771.x. [DOI] [PubMed] [Google Scholar]
- Payan D. G., Hess C. A., Goetzl E. J. Inhibition by somatostatin of the proliferation of T-lymphocytes and Molt-4 lymphoblasts. Cell Immunol. 1984 Apr 1;84(2):433–438. doi: 10.1016/0008-8749(84)90117-5. [DOI] [PubMed] [Google Scholar]
- Pinching A. J., Nye K. E. Defective signal transduction--a common pathway for cellular dysfunction in HIV infection? Immunol Today. 1990 Jul;11(7):256–259. doi: 10.1016/0167-5699(90)90100-n. [DOI] [PubMed] [Google Scholar]
- Reisine T., Bell G. I. Molecular biology of somatostatin receptors. Endocr Rev. 1995 Aug;16(4):427–442. doi: 10.1210/edrv-16-4-427. [DOI] [PubMed] [Google Scholar]
- Renold F. K., Dazin P., Goetzl E. J., Payan D. G. Interleukin-3 modulation of mouse bone marrow derived mast cell receptors for somatostatin. J Neurosci Res. 1987;18(1):195–202. doi: 10.1002/jnr.490180128. [DOI] [PubMed] [Google Scholar]
- Robberecht P., Abello J., Damien C., de Neef P., Vervisch E., Hooghe R., Christophe J. Variable stimulation of adenylate cyclase activity by vasoactive intestinal-like peptides and beta-adrenergic agonists in murine T cell lymphomas of immature, helper, and cytotoxic types. Immunobiology. 1989 Oct;179(4-5):422–431. doi: 10.1016/s0171-2985(89)80046-4. [DOI] [PubMed] [Google Scholar]
- Robbins S. J., Rapp F. Inhibition of measles virus replication by cyclic AMP. Virology. 1980 Oct 30;106(2):317–326. doi: 10.1016/0042-6822(80)90255-x. [DOI] [PubMed] [Google Scholar]
- Ruegg C. L., Strand M. Inhibition of protein kinase C and anti-CD3-induced Ca2+ influx in Jurkat T cells by a synthetic peptide with sequence identity to HIV-1 gp41. J Immunol. 1990 May 15;144(10):3928–3935. [PubMed] [Google Scholar]
- Scicchitano R., Dazin P., Bienenstock J., Payan D. G., Stanisz A. M. The murine IgA-secreting plasmacytoma MOPC-315 expresses somatostatin receptors. J Immunol. 1988 Aug 1;141(3):937–941. [PubMed] [Google Scholar]
- Seamon K. B., Padgett W., Daly J. W. Forskolin: unique diterpene activator of adenylate cyclase in membranes and in intact cells. Proc Natl Acad Sci U S A. 1981 Jun;78(6):3363–3367. doi: 10.1073/pnas.78.6.3363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Sreedharan S. P., Kodama K. T., Peterson K. E., Goetzl E. J. Distinct subsets of somatostatin receptors on cultured human lymphocytes. J Biol Chem. 1989 Jan 15;264(2):949–952. [PubMed] [Google Scholar]
- Stanisz A. M., Scicchitano R., Payan D. G., Bienenstock J. In vitro studies of immunoregulation by substance P and somatostatin. Ann N Y Acad Sci. 1987;496:217–225. doi: 10.1111/j.1749-6632.1987.tb35769.x. [DOI] [PubMed] [Google Scholar]
- Tamir A., Isakov N. Cyclic AMP inhibits phosphatidylinositol-coupled and -uncoupled mitogenic signals in T lymphocytes. Evidence that cAMP alters PKC-induced transcription regulation of members of the jun and fos family of genes. J Immunol. 1994 Apr 1;152(7):3391–3399. [PubMed] [Google Scholar]
- Weinstock J. V., Blum A. M., Malloy T. Macrophages within the granulomas of murine Schistosoma mansoni are a source of a somatostatin 1-14-like molecule. Cell Immunol. 1990 Dec;131(2):381–390. doi: 10.1016/0008-8749(90)90262-p. [DOI] [PubMed] [Google Scholar]
- Weiss A., Wiskocil R. L., Stobo J. D. The role of T3 surface molecules in the activation of human T cells: a two-stimulus requirement for IL 2 production reflects events occurring at a pre-translational level. J Immunol. 1984 Jul;133(1):123–128. [PubMed] [Google Scholar]
- Yanagi Y., Cubitt B. A., Oldstone M. B. Measles virus inhibits mitogen-induced T cell proliferation but does not directly perturb the T cell activation process inside the cell. Virology. 1992 Mar;187(1):280–289. doi: 10.1016/0042-6822(92)90316-h. [DOI] [PubMed] [Google Scholar]
